Thalidomide 4'-oxyacetamide-alkyl-C2-amine (hydrochloride), 100mg

3-[2-[2-[2-(3-methoxy-3-oxo-propoxy)ethoxy]ethoxy]ethoxy]propanoic acid, 100mg

(3-Bromo-2-methylphenyl)methanol, 97.0%, 250mg

Copper (II) sulphate, min. 99%, Ph.Eur., anhydrous, 1 kg, plastic packaging.

2-FLUORO-2-(3-FLUOROPHENYL)ACETIC ACID, 95%, 250mg

4-Ethylpyridin-2-amine, 95.0%, 10g

4-Acetamidopiperidine>98.0%(GC)(T)25g

6-Bromo-4,7-difluoroindoline-2,3-dione, 98%, 250mg

2-Phenylquinoline, 97.0%, 1g

1,2-Bis(4-ethynylphenyl)-1,2-diphenylethene, 97%, 5g

2-(Morpholin-4-yl)-5-(piperidine-1-sulfonyl)benzoic acid, 97%, 100mg

Infinity corrected plan phase S100x/1.25 objective. Working distance 0.18 mm

2,2-Bis[3,5-dibromo-4-(2,3-dibromopropoxy)phenyl]propane>95.0%(T)25g